CJC-1295 (No DAC) + Ipamorelin Research Guide
Educational Overview • Scientific Background • Current Research
Article Details
🕒 Estimated Reading Time: 10–12 minutes
📅 Last Reviewed: August 2026
📚 Research Category: Growth Hormone & Endocrine Research
🔬 Evidence Level: Human & Preclinical Research
📖 Article Type: Educational Research Guide
What Is CJC-1295 (No DAC) + Ipamorelin?
CJC-1295 (No DAC) + Ipamorelin is a multi-peptide research combination frequently studied in laboratory models involving growth hormone physiology, endocrine signaling, metabolism, recovery biology, and healthy aging research.
The blend combines two different peptide classes that influence growth hormone release through separate biological pathways.
CJC-1295 (No DAC) is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH), which stimulates receptors in the pituitary gland responsible for initiating natural growth hormone secretion.
Ipamorelin is a selective Growth Hormone Secretagogue (GHS) that activates the ghrelin receptor (GHS-R1a), providing a separate signaling pathway involved in endogenous growth hormone release.
Because these peptides act through different receptors, researchers frequently investigate them together when studying natural growth hormone physiology.
Check it out here: https://researchpeps.org/product/cjc-1295-no-dac-ipamorelin-5mg-5mg/
Research Snapshot
Category Information
Research Name CJC-1295 (No DAC) + Ipamorelin
Classification Multi-Peptide Growth Hormone Research Blend
Research Status Investigational Research Blend
Primary Research Areas Growth Hormone Physiology, Endocrine Biology, IGF-1 Signaling, Metabolism, Healthy Aging
Evidence Level Human & Preclinical Research
Related Systems GHRH & Ghrelin Receptor Signaling
At a Glance
What is CJC-1295 + Ipamorelin?
A research blend combining a GHRH analog with a selective Growth Hormone Secretagogue.
Why is it researched?
Researchers investigate how two separate endocrine signaling pathways influence natural growth hormone physiology.
Current Evidence
Published studies continue examining both peptides independently and in combination within laboratory research.
Human Use
This article summarizes scientific literature for educational purposes only.
Why Researchers Study This Combination
One reason researchers are interested in this blend is because each peptide stimulates endogenous growth hormone release through a different biological mechanism.
CJC-1295 (No DAC)
Stimulates:
✔ Growth Hormone-Releasing Hormone receptors
Ipamorelin
Stimulates:
✔ Ghrelin receptors (GHS-R1a)
Researchers continue studying whether activation of both pathways produces different physiological responses than either compound alone.
Current research interests include:
🧬 Growth Hormone Physiology
📈 IGF-1 Biology
⚖️ Metabolism
💪 Body Composition
😴 Sleep Biology
🧠 Healthy Aging
Understanding CJC-1295 (DAC) vs CJC-1295 (No DAC)
One of the most common questions in peptide research involves the difference between CJC-1295 with DAC and CJC-1295 without DAC.
Although both compounds are derived from the same Growth Hormone-Releasing Hormone analog, they behave differently because of one important modification: the Drug Affinity Complex (DAC).
What is DAC?
DAC stands for Drug Affinity Complex.
It is a molecular attachment designed to bind the peptide to albumin, a naturally occurring protein found in the bloodstream.
By attaching to albumin, the peptide remains in circulation much longer before being broken down.
This results in a substantially longer half-life compared to the No DAC version.
CJC-1295 (No DAC)
Researchers choose the No DAC version when studying:
✔ Shorter biological activity
✔ Natural pulsatile growth hormone release
✔ More physiologic endocrine signaling
✔ Multiple daily pulse research
Its shorter duration more closely resembles the body's normal growth hormone secretion pattern.
CJC-1295 (DAC)
Researchers investigate the DAC version because it:
✔ Remains active significantly longer
✔ Produces prolonged receptor stimulation
✔ Has a different pharmacokinetic profile
✔ Allows extended observation of growth hormone physiology
Which Version Is Better?
Neither version is considered "better."
Instead, researchers select the version that best matches the objectives of a particular study.
Studies focused on natural hormone pulses often investigate No DAC, while studies evaluating prolonged stimulation may utilize DAC.
Why Pair No DAC with Ipamorelin?
Researchers frequently combine No DAC with Ipamorelin because each peptide activates a different endocrine signaling pathway.
Rather than competing for the same receptor, they complement one another by stimulating separate mechanisms involved in endogenous growth hormone release.
Current research explores:
🧬 Endocrine regulation
📈 IGF-1 production
⚖️ Metabolic physiology
💪 Body composition
😴 Sleep-associated hormone release
🔬 Healthy aging biology
Current Areas of Scientific Investigation
Growth Hormone Physiology
Researchers study how the GHRH and ghrelin receptor pathways interact during endogenous hormone release.
IGF-1 Signaling
Growth hormone stimulates production of insulin-like growth factor-1 (IGF-1), making this pathway an important research focus.
Metabolism
Laboratory studies continue examining metabolic regulation and endocrine function.
Body Composition
Researchers investigate growth hormone physiology in relation to lean tissue and adipose tissue biology.
Sleep Biology
Because endogenous growth hormone secretion naturally increases during deep sleep, researchers continue examining sleep-associated endocrine physiology.
Healthy Aging
Age-related endocrine changes remain an active area of investigation involving growth hormone-releasing peptides.
Quick Facts
✔ Combines two different growth hormone pathways
✔ GHRH analog + Growth Hormone Secretagogue
✔ Investigated in endocrine physiology
✔ Human and laboratory research available
✔ Frequently studied in metabolism and aging biology
Important Scientific Considerations
The presence of two peptides does not automatically imply greater biological effects.
Researchers evaluate the combination as its own formulation while recognizing that each peptide contributes through separate physiological pathways.
Although both compounds have been studied individually, additional investigation continues regarding their combined biological activity.
Key Takeaways
✔ CJC-1295 (No DAC) stimulates GHRH receptors.
✔ Ipamorelin stimulates ghrelin receptors.
✔ Researchers investigate both pathways together because they regulate endogenous growth hormone differently.
✔ DAC and No DAC differ primarily in duration of activity.
✔ Additional research continues regarding endocrine physiology and combination peptide biology.
Continue Exploring Related Research
Related Growth Hormone & Endocrine Research
Explore another GHRH analog involved in natural growth hormone regulation.
Research involving metabolism and endocrine physiology.
➡️ CJC-1295 (No DAC) Research Guide
Learn more about the individual GHRH analog and how it differs from the DAC version.
Explore selective ghrelin receptor research.
Investigate reproductive hormone signaling and endocrine regulation.
Research involving gonadotropin physiology and hormone biology.
Further Reading
The publications below represent foundational research involving Growth Hormone-Releasing Hormone analogs, Ipamorelin, ghrelin receptor signaling, and endocrine physiology.
Selected References
CJC-1295
1. Teichman SL, et al. (2006). Prolonged stimulation of growth hormone and IGF-1 secretion by CJC-1295 in healthy adults. Journal of Clinical Endocrinology & Metabolism.
2. Mayo KE, et al. (2000). Growth Hormone-Releasing Hormone: Physiology and clinical applications. Endocrine Reviews.
Ipamorelin
3. Raun K, et al. (1998). Ipamorelin: A selective growth hormone secretagogue. European Journal of Endocrinology.
4. Smith RG, et al. (2005). Growth hormone secretagogue receptor biology. Endocrine Reviews.
Growth Hormone Physiology
5. Veldhuis JD, Iranmanesh A. (2006). Neuroendocrine regulation of growth hormone secretion. Endocrine Reviews.
6. Giustina A, Veldhuis JD. (1998). Pathophysiology of the somatotropic axis. Endocrine Reviews.
Educational Notice
The information presented in this article is intended solely for educational and informational purposes regarding published scientific research.
CJC-1295 (No DAC) and Ipamorelin are investigational research peptides. References to scientific studies describe published laboratory, preclinical, and human research and should not be interpreted as evidence of safety or effectiveness for any particular use.
This content is not medical advice and should not be used to make healthcare decisions.